Clinical Trial: Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: OSA
Study Type: INTERVENTIONAL
Official Title: Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
Brief Summary:
Current therapies available for obstructive sleep apnea (OSA) have varying degrees of efficacy due to the complex nature of the disorder.A reduction in pharyngeal muscle activity characterizes OSA, and recent research has shown that combining atomoxetine and oxybutynin improves OSA severity.Thus this may be a viable treatment option.However, the specific effects of these agents alone and in combination on pharyngeal muscle activity remain unknown.The current study will look at the impact of each drug on pharyngeal…
Read more